3D-QSAR Study on Histone Deacetylase Inhibitors (HDACIs) as Anti-Cancer Agents (Record no. 103569)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 00727ngm a22001937a 4500 |
| 003 - CONTROL NUMBER IDENTIFIER | |
| control field | OSt |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20170601142458.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 160623b xxu||||| |||| 00| 0 eng d |
| 040 ## - CATALOGING SOURCE | |
| Transcribing agency | |
| 082 ## - DEWEY DECIMAL CLASSIFICATION NUMBER | |
| Edition number | SIN |
| 100 ## - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Singh, Alka K. |
| 9 (RLIN) | 4519 |
| 245 ## - TITLE STATEMENT | |
| Title | 3D-QSAR Study on Histone Deacetylase Inhibitors (HDACIs) as Anti-Cancer Agents |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. (IMPRINT) | |
| Place of publication, distribution, etc. | Ahmedabad |
| Name of publisher, distributor, etc. | Institute of Pharmacy, Nirma University |
| Date of publication, distribution, etc. | 2016 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 78p. |
| 500 ## - GENERAL NOTE | |
| General note | Guided by Ms. Palak K. Parikh |
| 600 ## - SUBJECT ADDED ENTRY--PERSONAL NAME | |
| Source of heading or term | 615.19 |
| 856 ## - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="ftp://10.1.15.150/B.Pharm%20Project/2016%20B.Pharm%20Project/PPR00589-3D-QSAR%20Study%20on%20Histone%20Deacetylase%20Inhibitors%20(HDACIs)%20as%20Anti-Cancer%20Agents-12BPH004.pdf">ftp://10.1.15.150/B.Pharm%20Project/2016%20B.Pharm%20Project/PPR00589-3D-QSAR%20Study%20on%20Histone%20Deacetylase%20Inhibitors%20(HDACIs)%20as%20Anti-Cancer%20Agents-12BPH004.pdf</a> |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) | |
| Source of classification or shelving scheme | Dewey Decimal Classification |
| Koha item type | Project Report |
No items available.